Neuralstem, Inc. | Business Contracts

Form of Underwriter Warrant issued August 16, 2022 (Filed With SEC on November 14, 2022)

Separation Agreement and Release with former Chief Executive Officer (Filed With SEC on October 14, 2022)

First Amendment dated July 14, 2022 to the Office Lease Between AP Beacon Carlsbad, LP, and Palisade Bio, Inc., dated May 12, 2022 (Filed With SEC on August 15, 2022)

Form of Lock-Up and Voting Agreement (Filed With SEC on August 11, 2022)

Form of Leak-Out Agreement (Filed With SEC on August 11, 2022)

License Agreement, by and between Palisade Bio, Inc. and The Regents of the University of California, dated July 6, 2021 (Filed With SEC on March 17, 2022)

Agreement and Plan of Merger, dated as of December 16, 2020, by and among Seneca Biopharma, Inc., Leading BioSciences, Inc. and Townsgate Acquisition Sub 1, Inc (Filed With SEC on December 21, 2020)

Warrant Agency Agreement dated August 16, 2022, by and between Palisade Bio, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on August 16, 2022)

Form of Series 2 Warrant (Filed With SEC on August 16, 2022)

Form of Series 1 Warrant (Filed With SEC on August 16, 2022)

Underwriting Agreement dated as of August 12, 2022, by and between Palisade bio, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on August 16, 2022)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on August 11, 2022)

Form of Underwriting Agreement (Filed With SEC on August 11, 2022)

Form of Underwriting Agreement (Filed With SEC on August 10, 2022)

Form of Waiver and Right of Participation Letter Agreement (Filed With SEC on August 9, 2022)

Form of Leak-Out Agreement (Filed With SEC on August 9, 2022)

Form of Series B Preferred Stock Certificate of Registrant (Filed With SEC on August 9, 2022)

Form of Warrant Agency Agreement (Filed With SEC on August 9, 2022)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on August 9, 2022)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on August 2, 2022)

Form of Underwriting Agreement (Filed With SEC on August 2, 2022)

Form of Warrant Agency Agreement (Filed With SEC on August 2, 2022)

Form of Lock-Up and Voting Agreement (Filed With SEC on August 2, 2022)

Office Lease Between AP Beacon Carlsbad, LP, and Palisade Bio, Inc., dated May 12, 2022 (Filed With SEC on May 13, 2022)

Placement Agency Agreement, dated May 6, 2022, by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on May 6, 2022)

Form of Placement Agent Warrant (Filed With SEC on May 6, 2022)

Form of Securities Purchase Agreement, dated May 6, 2022, by and among the Company and the purchasers named therein (Filed With SEC on May 6, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on May 6, 2022)

Specimen Common Stock Certificate (Filed With SEC on March 17, 2022)

Description of Securities (Filed With SEC on March 17, 2022)

Non-Employee Director Compensation Policy (Filed With SEC on March 17, 2022)

Asset Transfer Agreement, by and between Alto Neuroscience, Inc. and Palisade Bio, Inc., dated October 18, 2021 (Filed With SEC on March 17, 2022)

Warrant, dated as of January 31, 2022, issued to Altium Growth Fund, LP (Filed With SEC on February 1, 2022)

Waiver Agreement, dated as of January 31, 2022, by and between Palisade Bio, Inc. and Altium Growth Fund, LP (Filed With SEC on February 1, 2022)

Palisade Bio, Inc. 2021 Equity Incentive Plan, as amended (Filed With SEC on November 23, 2021)

Form of Non-Employee Director Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Palisade Bio, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 23, 2021)

Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Palisade Bio, Inc. 2021 Equity Incentive Plan (Filed With SEC on November 23, 2021)

Palisade Bio, Inc. 2021 Inducement Incentive Plan (Filed With SEC on November 23, 2021)

Warrant, dated as of August 19, 2021, issued to Yuma Regional Medical Center (Filed With SEC on August 24, 2021)

Securities Purchase Agreement, dated as of August 19, 2021, by and between Palisade Bio, Inc. and Yuma Regional Medical Center (Filed With SEC on August 24, 2021)

2021 Employee Stock Purchase Plan (Filed With SEC on August 23, 2021)

2021 Equity Incentive Plan (Filed With SEC on August 23, 2021)

Waiver Agreement, dated as of July 21, 2021, by and between Palisade Bio, Inc. and Altium Growth Fund, LP (Filed With SEC on July 22, 2021)

Warrant, dated as of July 21, 2021, issued to Altium Growth Fund, LP (Filed With SEC on July 22, 2021)

Amendment Agreement to Securities Purchase Agreement by and among, the Company, Leading BioSciences, Inc. and Altium Growth Fund, LP, dated May 3, 2021 (Filed With SEC on May 14, 2021)

Contingent Value Rights Agreement, dated as of April 27, 2021, by and among the Company, American Stock Transfer & Trust Company, LLC and Raul Silvestre (Filed With SEC on April 27, 2021)

Form of Separation Agreement (Filed With SEC on March 18, 2021)

Leading BioSciences, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement and... (Filed With SEC on December 23, 2020)

Executive Employment Agreement, by and between Leading BioSciences, Inc. and JD Finley, dated December 16, 2020 (Filed With SEC on December 23, 2020)

Executive Employment Agreement, by and between Leading BioSciences, Inc. and Thomas Hallam, Ph.D., dated December 16, 2020 (Filed With SEC on December 23, 2020)

Executive Employment Agreement, by and between Leading BioSciences, Inc. and Michael Dawson, M.D., dated December 16, 2020 (Filed With SEC on December 23, 2020)

Co-Development and Distribution Agreement, by and between Leading BioSciences, Inc. and Newsoara Biopharma Co., Ltd. (as successor-in-interest to Biolead Medical Technology... (Filed With SEC on December 23, 2020)

License Agreement, by and between Leading BioSciences, Inc. and The Regents of the University of California, dated April 1, 2020 (Filed With SEC on December 23, 2020)

License Agreement, by and between Leading BioSciences, Inc. and The Regents of the University of California, dated August 19, 2015, as amended on December 20, 2019 (Filed With SEC on December 23, 2020)

Form of Senior Secured Note of Leading BioSciences, Inc (Filed With SEC on December 23, 2020)

Form of Warrant to Purchase Shares of Common Stock of Leading BioSciences, Inc (Filed With SEC on December 23, 2020)

Form of Bridge Warrant (Filed With SEC on December 21, 2020)

Form of Company Support Agreement, dated as of December 16, 2020, by and between Leading BioSciences, Inc. and each of the parties named in each agreement therein (Filed With SEC on December 21, 2020)

Form of CVR Agreement (Filed With SEC on December 21, 2020)

Registration Rights Agreement, by and between Seneca Biopharma, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)

Form of Equity Warrant (Filed With SEC on December 21, 2020)

Form of LBS Support Agreement, dated as of December 16, 2020, by and between Seneca Biopharma, Inc. and each of the parties named in each agreement therein (Filed With SEC on December 21, 2020)

Form of LBS Lock-Up Agreement (Filed With SEC on December 21, 2020)

Form of Company Lock-Up Agreement (Filed With SEC on December 21, 2020)

Securities Purchase Agreement, by and between Leading BioSciences, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)

Securities Purchase Agreement, by and among Seneca Biopharma, Inc., Leading BioSciences, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)

Form of Leak-Out Agreement, by and between Seneca Biopharma, Inc. and the investor party thereto (Filed With SEC on December 21, 2020)

Form of Securities Purchase Agreement (Filed With SEC on May 27, 2020)

Form of Placement Agent Warrant (Filed With SEC on May 27, 2020)

Employment Agreement with Dane Saglio (Filed With SEC on April 2, 2020)

Employment Agreement with Matthew Kalnik, PhD (Filed With SEC on April 2, 2020)

Inducement Stock Option Plan adopted 2/15/2016 and as amended on 12/12/2018, 9/13/2019, and 3/23/20 (Filed With SEC on March 27, 2020)

Amendment to Employment Agreement with Kenneth Carter effective April 1,2020 (Filed With SEC on March 27, 2020)

Form of Placement Agent Agreement (Filed With SEC on January 22, 2020)

Letter Agreement dated January 17, 2020 (Filed With SEC on January 22, 2020)

Form of Placement Agent Warrant (Filed With SEC on January 22, 2020)

Form of Replacement Warrant (Series Q) (Filed With SEC on January 22, 2020)

Form of Replacement Warrant (Series P) (Filed With SEC on January 22, 2020)

NEURALSTEM, INC. AMENDED AND RESTATED INDUCEMENT AWARD STOCK OPTION PLAN (Filed With SEC on November 14, 2019)

Form of Series O Pre-Funded Warrant (Filed With SEC on July 24, 2019)

Form of Series M and Series N Warrant (Filed With SEC on July 24, 2019)

Form of Underwriting Agreement (Filed With SEC on July 24, 2019)

Form of Restricted Stock Unit from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)

Form of Restricted Stock Grant from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)

Form of Stock Option Grant from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)

Consultant Warrant for Hibiscus BioVentures, LLC issued January 2019 (Filed With SEC on May 14, 2019)

Inducement Stock Option Plan adopted 2/15/2016 and as amended on 12/12/2018 (Filed With SEC on March 22, 2019)

Neuralstem, Inc. (87)